Futurity September 23, 2024
ETH Zurich

Researchers have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumor cells in glioblastoma—at least in a cell-culture dish.

Glioblastoma is a particularly aggressive brain tumor that at present is incurable.

Cancer doctors can extend patients’ life expectancy through operations, radiation, chemotherapy, or surgical interventions. Nevertheless, half of patients die within twelve months of diagnosis.

Drugs that are effective against brain tumors are difficult to find, as many cancer drugs often can’t cross the blood-brain barrier to reach the brain. This limits the choice of possible treatments. Neuro-oncologists have been searching intensively for some time to find better drugs that can reach the brain and eliminate the tumor.

Researchers led by...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More
Pharma Pulse 11/25/24: Deepening Patient Relationships,
Halozyme abandons its €2bn pursuit of Evotec
BridgeBio poised to challenge Pfizer after Attruby approval
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy

Share This Article